Lupin, a drug company headquartered in Mumbai, recently earned FDA approval for its Amabelz tablets.
Amabelz tablets are the generic equivalent of the brand name Activella tablets produced by Bridgewater, N.J.-based Amneal Pharmaceuticals. Amabelz tablets are intended to prevent postmenopausal osteoporosis, as well as treat symptoms caused by menopause including moderate to severe vasomotor symptoms and vaginal atrophy.
Last year, Activella had U.S. sales of $95.6 million.
More articles on supply chain:
As childhood diabetes rates rise, so do treatment costs: 5 things to know
One-third of cancer patients suffer financial hardship due to drug costs: 4 things to know
How Mayo Clinic is diversifying its suppliers